Skip to main content

BioNTech SE (NASDAQ: BNTX) Investor Securities Class Action Lawsuit 01/16/2024

  • If you purchased a significant amount of shares of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and October 13, 2023, and / or if you purchased any NASDAQ: BNTX shares prior to March 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 12, 2024. NASDAQ: BNTX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 16, 2024 - An investor in shares of BioNTech SE (NASDAQ: BNTX) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by BioNTech SE in connection with certain allegedly false and misleading statements made between March 30, 2022 and October 13, 2023. Germany based BioNTech SE, a biotechnology compan...

You must register (for free) or login to view the entire case.